Return a single markdown document with these sections:
- Executive Summary
- Deterministic Assessment (algorithm decision, rationale)
- Treatment Recommendation (regimen, dose, frequency, duration; acceptable alternatives; contraindications)
- Safety Validation (DDIs, renal/pregnancy considerations; approval/modify/reject with rationale; monitoring)
- Clinical Reasoning Narrative (differential diagnosis and confidence score)
- Prescribing Considerations tailored to CA-ON (include regional resistance context)
- Research Summary with citations (concise, credible sources)
- 72-Hour Follow-Up Plan (monitoring checklist, special instructions)
- Diagnosis Brief (provider-ready narrative)

Use current evidence-based guidelines, tailor recommendations to patient factors and regional resistance, and keep each section concise and actionable." \
  --judge-model gpt-4o \
  --agent-models "o4-mini-deep-research-2025-06-26,gpt-4o,gpt-4o-mini,gpt-5,gpt-4.1" \
  --min-preview-tokens 200 \
  --strategy bandit \
  --bandit-alpha 1.5 \
  --bandit-ridge 1e-2 \
  --bandit-state .router_state.json \
  --bandit-length-threshold 2000 \
  --bandit-quality-weight 0.8 \
  --bandit-speed-weight 0.2
Using CPython 3.12.11
Creating virtual environment at: .venv
      Built parallel-agents @ file:///Users/terence/Documents/agentic-patterns/parallel_agents
Installed 46 packages in 316ms
2025-09-04 13:01:05,131 - src.race - INFO - ================================================================================
2025-09-04 13:01:05,131 - src.race - INFO - Starting parallel deep research run
2025-09-04 13:01:05,131 - src.race - INFO - Query: Generate a comprehensive, provider-ready UTI assessment and plan for Sarah Smith, a 28-year-old non-pregnant female in region CA-ON with normal renal function. Presenting symptoms: dysuria and urgency. Denies: frequency, suprapubic pain, hematuria. No red flags: fever, rigors, flank pain, nausea/vomiting, systemic illness. History: no antibiotics in last 90 days; no allergies; no current meds; no ACEI/ARB use; no indwelling catheter; no urinary stones; not immunocompromised. Recurrence markers: none (no relapse within 4 weeks; not recurrent at 6 or 12 months).

Return a single markdown document with these sections:
- Executive Summary
- Deterministic Assessment (algorithm decision, rationale)
- Treatment Recommendation (regimen, dose, frequency, duration; acceptable alternatives; contraindications)
- Safety Validation (DDIs, renal/pregnancy considerations; approval/modify/reject with rationale; monitoring)
- Clinical Reasoning Narrative (differential diagnosis and confidence score)
- Prescribing Considerations tailored to CA-ON (include regional resistance context)
- Research Summary with citations (concise, credible sources)
- 72-Hour Follow-Up Plan (monitoring checklist, special instructions)
- Diagnosis Brief (provider-ready narrative)

Use current evidence-based guidelines, tailor recommendations to patient factors and regional resistance, and keep each section concise and actionable.
2025-09-04 13:01:05,131 - src.race - INFO - Min tokens per preview: 200
2025-09-04 13:01:05,131 - src.race - INFO - ================================================================================
2025-09-04 13:01:05,132 - src.race - INFO - Starting parallel preview generation
2025-09-04 13:01:05,132 - src.streaming - INFO - Starting stream for Candidate A[gpt-5] with min_tokens=200
2025-09-04 13:01:05,133 - src.streaming - INFO - Starting stream for Candidate B[o4-mini-deep-research-2025-06-26] with min_tokens=200
2025-09-04 13:01:05,133 - src.streaming - INFO - Starting stream for Candidate C[gpt-4o-mini] with min_tokens=200
2025-09-04 13:01:05,134 - src.streaming - INFO - Starting stream for Candidate D[gpt-4.1] with min_tokens=200
2025-09-04 13:01:05,134 - src.streaming - INFO - Starting stream for Candidate E[gpt-4o] with min_tokens=200
2025-09-04 13:01:06,469 - httpx - INFO - HTTP Request: POST https://api.openai.com/v1/responses "HTTP/1.1 200 OK"
2025-09-04 13:01:06,536 - httpx - INFO - HTTP Request: POST https://api.openai.com/v1/responses "HTTP/1.1 200 OK"
2025-09-04 13:01:06,593 - httpx - INFO - HTTP Request: POST https://api.openai.com/v1/responses "HTTP/1.1 200 OK"
2025-09-04 13:01:06,730 - httpx - INFO - HTTP Request: POST https://api.openai.com/v1/responses "HTTP/1.1 200 OK"
2025-09-04 13:01:06,735 - httpx - INFO - HTTP Request: POST https://api.openai.com/v1/responses "HTTP/1.1 200 OK"
2025-09-04 13:01:07,321 - src.streaming - INFO - Candidate E[gpt-4o]: 20/200 tokens
2025-09-04 13:01:07,454 - src.streaming - INFO - Candidate D[gpt-4.1]: 20/200 tokens
2025-09-04 13:01:07,580 - src.streaming - INFO - Candidate E[gpt-4o]: 40/200 tokens
2025-09-04 13:01:07,757 - src.streaming - INFO - Candidate E[gpt-4o]: 60/200 tokens
2025-09-04 13:01:07,881 - src.streaming - INFO - Candidate D[gpt-4.1]: 40/200 tokens
2025-09-04 13:01:08,077 - src.streaming - INFO - Candidate E[gpt-4o]: 80/200 tokens
2025-09-04 13:01:08,138 - src.streaming - INFO - Candidate C[gpt-4o-mini]: 20/200 tokens
2025-09-04 13:01:08,244 - src.streaming - INFO - Candidate D[gpt-4.1]: 60/200 tokens
2025-09-04 13:01:08,355 - src.streaming - INFO - Candidate E[gpt-4o]: 100/200 tokens
2025-09-04 13:01:08,511 - src.streaming - INFO - Candidate D[gpt-4.1]: 80/200 tokens
2025-09-04 13:01:08,621 - src.streaming - INFO - Candidate E[gpt-4o]: 120/200 tokens
2025-09-04 13:01:08,623 - src.streaming - INFO - Candidate C[gpt-4o-mini]: 40/200 tokens
2025-09-04 13:01:08,921 - src.streaming - INFO - Candidate E[gpt-4o]: 140/200 tokens
2025-09-04 13:01:08,956 - src.streaming - INFO - Candidate D[gpt-4.1]: 100/200 tokens
2025-09-04 13:01:09,199 - src.streaming - INFO - Candidate E[gpt-4o]: 160/200 tokens
2025-09-04 13:01:09,365 - src.streaming - INFO - Candidate C[gpt-4o-mini]: 60/200 tokens
2025-09-04 13:01:09,426 - src.streaming - INFO - Candidate D[gpt-4.1]: 120/200 tokens
2025-09-04 13:01:09,574 - src.streaming - INFO - Candidate E[gpt-4o]: 180/200 tokens
2025-09-04 13:01:09,729 - src.streaming - INFO - Candidate C[gpt-4o-mini]: 80/200 tokens
2025-09-04 13:01:09,859 - src.streaming - INFO - Candidate D[gpt-4.1]: 140/200 tokens
2025-09-04 13:01:09,944 - src.streaming - INFO - Candidate E[gpt-4o]: 200/200 tokens
2025-09-04 13:01:09,944 - src.streaming - INFO - Candidate E[gpt-4o]: Reached 200 tokens, stopping early
2025-09-04 13:01:09,944 - src.streaming - INFO - Candidate E[gpt-4o]: Preview complete - 200 tokens, 1083 chars, 4.81s
2025-09-04 13:01:10,307 - src.streaming - INFO - Candidate D[gpt-4.1]: 160/200 tokens
2025-09-04 13:01:10,393 - src.streaming - INFO - Candidate C[gpt-4o-mini]: 100/200 tokens
2025-09-04 13:01:10,663 - src.streaming - INFO - Candidate D[gpt-4.1]: 180/200 tokens
2025-09-04 13:01:10,753 - src.streaming - INFO - Candidate C[gpt-4o-mini]: 120/200 tokens
2025-09-04 13:01:10,978 - src.streaming - INFO - Candidate D[gpt-4.1]: 200/200 tokens
2025-09-04 13:01:10,978 - src.streaming - INFO - Candidate D[gpt-4.1]: Reached 200 tokens, stopping early
2025-09-04 13:01:10,978 - src.streaming - INFO - Candidate D[gpt-4.1]: Preview complete - 200 tokens, 970 chars, 5.84s
2025-09-04 13:01:11,176 - src.streaming - INFO - Candidate C[gpt-4o-mini]: 140/200 tokens
2025-09-04 13:01:11,793 - src.streaming - INFO - Candidate C[gpt-4o-mini]: 160/200 tokens
2025-09-04 13:01:12,182 - src.streaming - INFO - Candidate C[gpt-4o-mini]: 180/200 tokens
2025-09-04 13:01:12,514 - src.streaming - INFO - Candidate C[gpt-4o-mini]: 200/200 tokens
2025-09-04 13:01:12,514 - src.streaming - INFO - Candidate C[gpt-4o-mini]: Reached 200 tokens, stopping early
2025-09-04 13:01:12,514 - src.streaming - INFO - Candidate C[gpt-4o-mini]: Preview complete - 200 tokens, 1140 chars, 7.38s
2025-09-04 13:01:39,239 - src.streaming - INFO - Candidate A[gpt-5]: 20/200 tokens
2025-09-04 13:01:39,774 - src.streaming - INFO - Candidate A[gpt-5]: 40/200 tokens
2025-09-04 13:01:39,952 - src.streaming - INFO - Candidate A[gpt-5]: 60/200 tokens
2025-09-04 13:01:40,325 - src.streaming - INFO - Candidate A[gpt-5]: 80/200 tokens
2025-09-04 13:01:40,680 - src.streaming - INFO - Candidate A[gpt-5]: 100/200 tokens
2025-09-04 13:01:41,200 - src.streaming - INFO - Candidate A[gpt-5]: 120/200 tokens
2025-09-04 13:01:41,530 - src.streaming - INFO - Candidate A[gpt-5]: 140/200 tokens
2025-09-04 13:01:41,911 - src.streaming - INFO - Candidate A[gpt-5]: 160/200 tokens
2025-09-04 13:01:42,221 - src.streaming - INFO - Candidate A[gpt-5]: 180/200 tokens
2025-09-04 13:01:42,586 - src.streaming - INFO - Candidate A[gpt-5]: 200/200 tokens
2025-09-04 13:01:42,586 - src.streaming - INFO - Candidate A[gpt-5]: Reached 200 tokens, stopping early
2025-09-04 13:01:42,586 - src.streaming - INFO - Candidate A[gpt-5]: Preview complete - 200 tokens, 755 chars, 37.45s
2025-09-04 13:04:03,076 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26]: 20/200 tokens
2025-09-04 13:04:04,508 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26]: 40/200 tokens
2025-09-04 13:04:04,992 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26]: 60/200 tokens
2025-09-04 13:04:05,511 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26]: 80/200 tokens
2025-09-04 13:04:05,583 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26]: 100/200 tokens
2025-09-04 13:04:05,607 - src.streaming - INFO - ðŸ”— Citation found (annotation): Infectious Diseases in Clinical Practice - https://journals.lww.com/infectdis/Fulltext/2011/07000/Highlights_From_International_Clinical_Practice.15.aspx#:~:text=,ofloxacin%2C%20ciprofloxacin%2C%20and%20levofloxacin%20are
2025-09-04 13:04:05,648 - src.streaming - INFO - ðŸ”— Citation found (annotation): Recommendations on Bacterial Infections Treatment - UHN - https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=Syndrome%20%20,3%20days%20Fosfomycin%3A%201%20day
2025-09-04 13:04:05,731 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26]: 120/200 tokens
2025-09-04 13:04:05,759 - src.streaming - INFO - ðŸ”— Citation found (annotation): Antibiotic susceptibility of urine culture specimens in Ontario: a population-based cohort study - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC9744262/#:~:text=Organism%20Escherichia%20coli%20%20,14.0
2025-09-04 13:04:05,831 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26]: 140/200 tokens
2025-09-04 13:04:05,918 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26]: 160/200 tokens
2025-09-04 13:04:05,957 - src.streaming - INFO - ðŸ”— Citation found (annotation): Dysuria - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/sites/books/NBK549918/#:~:text=Etiology
2025-09-04 13:04:05,998 - src.streaming - INFO - ðŸ”— Citation found (annotation): Dysuria - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/sites/books/NBK549918/#:~:text=Dysuria%20typically%20affects%20approximately%203,6
2025-09-04 13:04:06,107 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26]: 180/200 tokens
2025-09-04 13:04:06,215 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26]: 200/200 tokens
2025-09-04 13:04:06,215 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26]: Reached 200 tokens, stopping early
2025-09-04 13:04:06,215 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26]: Preview complete - 200 tokens, 1637 chars, 181.08s
2025-09-04 13:04:06,215 - src.race - INFO - All previews complete, sending to judge
2025-09-04 13:04:06,216 - src.judge - INFO - Starting judge evaluation of previews
2025-09-04 13:04:07,139 - httpx - INFO - HTTP Request: POST https://api.openai.com/v1/responses "HTTP/1.1 200 OK"
2025-09-04 13:04:13,206 - src.judge - INFO - Judge verdict: Winner is Candidate 1
2025-09-04 13:04:13,206 - src.judge - INFO -   Candidate 0 scores - Relevance: 0.70, Coverage: 0.80, Faithfulness: 0.80, Overall: 0.75
2025-09-04 13:04:13,206 - src.judge - INFO -   Candidate 1 scores - Relevance: 0.90, Coverage: 0.95, Faithfulness: 0.95, Overall: 0.90
2025-09-04 13:04:13,207 - src.judge - INFO -   Candidate 2 scores - Relevance: 0.60, Coverage: 0.60, Faithfulness: 0.70, Overall: 0.65
2025-09-04 13:04:13,207 - src.judge - INFO -   Candidate 3 scores - Relevance: 0.80, Coverage: 0.85, Faithfulness: 0.85, Overall: 0.80
2025-09-04 13:04:13,207 - src.judge - INFO -   Candidate 4 scores - Relevance: 0.75, Coverage: 0.80, Faithfulness: 0.80, Overall: 0.77
2025-09-04 13:04:13,207 - src.race - INFO - Selected candidate: Candidate B[o4-mini-deep-research-2025-06-26]
2025-09-04 13:04:13,208 - src.race - INFO - Generating full answer
2025-09-04 13:04:13,208 - src.streaming - INFO - Starting stream for Candidate B[o4-mini-deep-research-2025-06-26] (full) (full)
2025-09-04 13:04:13,502 - httpx - INFO - HTTP Request: POST https://api.openai.com/v1/responses "HTTP/1.1 200 OK"
2025-09-04 13:06:44,352 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=UTI%20is%20defined%20as%20a,10%2C10%20%2C%2018
2025-09-04 13:06:44,451 - src.streaming - INFO - ðŸ”— Citation found (annotation): Recommendations on Bacterial Infections Treatment - UHN - https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=UTI%20with%20NO%20systemic%20involvement,3%20days%20Fosfomycin%3A%201%20day
2025-09-04 13:06:44,606 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 50 tokens streamed
2025-09-04 13:06:44,962 - src.streaming - INFO - ðŸ”— Citation found (annotation): Recommendations on Bacterial Infections Treatment - UHN - https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=UTI%20with%20NO%20systemic%20involvement,3%20days%20Fosfomycin%3A%201%20day
2025-09-04 13:06:45,009 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=%E2%80%A2%E2%80%83Nitrofurantoin%20PO%20%C3%97%205%20days,14%20day
2025-09-04 13:06:45,177 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 100 tokens streamed
2025-09-04 13:06:45,383 - src.streaming - INFO - ðŸ”— Citation found (annotation): Recommendations on Bacterial Infections Treatment - UHN - https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=OR%20Ciprofloxacin%20500%20mg%20PO,3%20days%20Fosfomycin%3A%201%20day
2025-09-04 13:06:45,444 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Uncomplicated%5E%7B,%E2%80%A2%E2%80%83Ceftriaxone%20IV%20%C2%B1%20ampicillin%20IV
2025-09-04 13:06:45,706 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Also%2C%20the%20Food%20and%20Drug,line
2025-09-04 13:06:45,919 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 150 tokens streamed
2025-09-04 13:06:46,173 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Patients%20can%20usually%20expect%20to,promptly%20by%20a%20physician%20to
2025-09-04 13:06:46,575 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=UTI%20is%20defined%20as%20a,10%2C10%20%2C%2018
2025-09-04 13:06:46,664 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=In%20women%20with%20dysuria%2C%20if,18
2025-09-04 13:06:46,722 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 200 tokens streamed
2025-09-04 13:06:47,469 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 250 tokens streamed
2025-09-04 13:06:47,473 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=,2%20%2C%2018%2C19
2025-09-04 13:06:47,571 - src.streaming - INFO - ðŸ”— Citation found (annotation): Recommendations on Bacterial Infections Treatment - UHN - https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=Syndrome%20%20,500%20mg%20PO%20q12h%20OR
2025-09-04 13:06:48,136 - src.streaming - INFO - ðŸ”— Citation found (annotation): Recommendations on Bacterial Infections Treatment - UHN - https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=Syndrome%20%20,500%20mg%20PO%20q12h%20OR
2025-09-04 13:06:48,254 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Uncomplicated%5E%7B,%E2%80%A2%E2%80%83Ceftriaxone%20IV%20%C2%B1%20ampicillin%20IV
2025-09-04 13:06:48,474 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 300 tokens streamed
2025-09-04 13:06:48,875 - src.streaming - INFO - ðŸ”— Citation found (annotation): Recommendations on Bacterial Infections Treatment - UHN - https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=UTI%20with%20NO%20systemic%20involvement,3%20days%20Fosfomycin%3A%201%20day
2025-09-04 13:06:49,494 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 350 tokens streamed
2025-09-04 13:06:49,707 - src.streaming - INFO - ðŸ”— Citation found (annotation): Recommendations on Bacterial Infections Treatment - UHN - https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=UTI%20with%20NO%20systemic%20involvement,3%20days%20Fosfomycin%3A%201%20day
2025-09-04 13:06:49,836 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=%E2%80%A2%E2%80%83Nitrofurantoin%20PO%20%C3%97%205%20days,14%20day
2025-09-04 13:06:50,753 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 400 tokens streamed
2025-09-04 13:06:51,442 - src.streaming - INFO - ðŸ”— Citation found (annotation): Recommendations on Bacterial Infections Treatment - UHN - https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=OR%20Ciprofloxacin%20500%20mg%20PO,3%20days%20Fosfomycin%3A%201%20day
2025-09-04 13:06:51,703 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Uncomplicated%5E%7B,%E2%80%A2%E2%80%83Ceftriaxone%20IV%20%C2%B1%20ampicillin%20IV
2025-09-04 13:06:53,055 - src.streaming - INFO - ðŸ”— Citation found (annotation): Recommendations on Bacterial Infections Treatment - UHN - https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=OR%20Ciprofloxacin%20500%20mg%20PO,3%20days%20Fosfomycin%3A%201%20day
2025-09-04 13:06:53,386 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Uncomplicated%5E%7B,%E2%80%A2%E2%80%83Ceftriaxone%20IV%20%C2%B1%20ampicillin%20IV
2025-09-04 13:06:53,975 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 450 tokens streamed
2025-09-04 13:06:54,537 - src.streaming - INFO - ðŸ”— Citation found (annotation): Antibiotic susceptibility of urine culture specimens in Ontario: a population-based cohort study - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC9744262/#:~:text=Organism%20Escherichia%20coli%20%20,0
2025-09-04 13:06:54,668 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Uncomplicated%5E%7B,%E2%80%A2%E2%80%83Ceftriaxone%20IV%20%C2%B1%20ampicillin%20IV
2025-09-04 13:06:55,256 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 500 tokens streamed
2025-09-04 13:06:55,694 - src.streaming - INFO - ðŸ”— Citation found (annotation): Recommendations on Bacterial Infections Treatment - UHN - https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=Cystitis%20OR%20asymptomatic%20bacteriuria%20,7%20daysFosfomycin%3A%201
2025-09-04 13:06:56,536 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 550 tokens streamed
2025-09-04 13:06:57,663 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 600 tokens streamed
2025-09-04 13:06:58,195 - src.streaming - INFO - ðŸ”— Citation found (annotation): Recommendations on Bacterial Infections Treatment - UHN - https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=Cystitis%20OR%20asymptomatic%20bacteriuria%20,7%20daysFosfomycin%3A%201
2025-09-04 13:06:58,994 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 650 tokens streamed
2025-09-04 13:07:00,267 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 700 tokens streamed
2025-09-04 13:07:01,614 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 750 tokens streamed
2025-09-04 13:07:03,015 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 800 tokens streamed
2025-09-04 13:07:04,351 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 850 tokens streamed
2025-09-04 13:07:05,564 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 900 tokens streamed
2025-09-04 13:07:05,567 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=UTI%20is%20defined%20as%20a,10%2C10%20%2C%2018
2025-09-04 13:07:05,750 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=In%20women%20with%20dysuria%2C%20if,18
2025-09-04 13:07:07,026 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=In%20women%20with%20dysuria%2C%20if,18
2025-09-04 13:07:07,398 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 950 tokens streamed
2025-09-04 13:07:09,575 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1000 tokens streamed
2025-09-04 13:07:10,912 - src.streaming - INFO - ðŸ”— Citation found (annotation): Recommendations on Bacterial Infections Treatment - UHN - https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=OR%20Ciprofloxacin%20500%20mg%20PO,3%20days%20Fosfomycin%3A%201%20day
2025-09-04 13:07:12,503 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1050 tokens streamed
2025-09-04 13:07:14,019 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1100 tokens streamed
2025-09-04 13:07:14,527 - src.streaming - INFO - ðŸ”— Citation found (annotation): Recommendations on Bacterial Infections Treatment - UHN - https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=UTI%20with%20systemic%20involvement%20One,growth%20in%20the%20past%20year
2025-09-04 13:07:14,699 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=to%20the%20aforementioned%20factors%20should,emergency%20medical%20assessment%2C%20if%20present
2025-09-04 13:07:15,895 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1150 tokens streamed
2025-09-04 13:07:16,285 - src.streaming - INFO - ðŸ”— Citation found (annotation): Antibiotic susceptibility of urine culture specimens in Ontario: a population-based cohort study - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC9744262/#:~:text=Organism%20Escherichia%20coli%20%20,0
2025-09-04 13:07:19,092 - src.streaming - INFO - ðŸ”— Citation found (annotation): Antibiotic susceptibility of urine culture specimens in Ontario: a population-based cohort study - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC9744262/#:~:text=Organism%20Escherichia%20coli%20%20,0
2025-09-04 13:07:20,116 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1200 tokens streamed
2025-09-04 13:07:20,601 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Also%2C%20the%20Food%20and%20Drug,line
2025-09-04 13:07:22,826 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Also%2C%20the%20Food%20and%20Drug,mind%2C%20however%2C%20that%20resistance%20rates
2025-09-04 13:07:23,063 - src.streaming - INFO - ðŸ”— Citation found (annotation): Quality of antibiotic prescribing for outpatient cystitis in adult females | Journal of the Association of Medical Microbiology and Infectious Disease Canada - https://utppublishing.com/doi/10.3138/jammi-2023-0031#:~:text=
2025-09-04 13:07:23,161 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1250 tokens streamed
2025-09-04 13:07:24,904 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1300 tokens streamed
2025-09-04 13:07:27,227 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1350 tokens streamed
2025-09-04 13:07:30,021 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=UTI%20is%20defined%20as%20a,10%2C10%20%2C%2018
2025-09-04 13:07:30,253 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=In%20women%20with%20dysuria%2C%20if,18
2025-09-04 13:07:30,469 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1400 tokens streamed
2025-09-04 13:07:31,457 - src.streaming - INFO - ðŸ”— Citation found (annotation): Does clinical examination aid in the diagnosis of urinary tract infections in women? A systematic review and meta-analysis - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC3207883/#:~:text=Results
2025-09-04 13:07:32,565 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1450 tokens streamed
2025-09-04 13:07:32,990 - src.streaming - INFO - ðŸ”— Citation found (annotation): Recommendations on Bacterial Infections Treatment - UHN - https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=UTI%20with%20NO%20systemic%20involvement,3%20days%20Fosfomycin%3A%201%20day
2025-09-04 13:07:33,201 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Uncomplicated%5E%7B,%E2%80%A2%E2%80%83Ceftriaxone%20IV%20%C2%B1%20ampicillin%20IV
2025-09-04 13:07:34,459 - src.streaming - INFO - ðŸ”— Citation found (annotation): Recommendations on Bacterial Infections Treatment - UHN - https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=OR%20Ciprofloxacin%20500%20mg%20PO,3%20days%20Fosfomycin%3A%201%20day
2025-09-04 13:07:34,766 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Uncomplicated%5E%7B,%E2%80%A2%E2%80%83Ceftriaxone%20IV%20%C2%B1%20ampicillin%20IV
2025-09-04 13:07:35,608 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Uncomplicated%5E%7B,%E2%80%A2%E2%80%83Ceftriaxone%20IV%20%C2%B1%20ampicillin%20IV
2025-09-04 13:07:35,771 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1500 tokens streamed
2025-09-04 13:07:37,597 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Also%2C%20the%20Food%20and%20Drug,line
2025-09-04 13:07:38,212 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=fluoroquinolone%20resistance,8%2C11
2025-09-04 13:07:38,383 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1550 tokens streamed
2025-09-04 13:07:39,286 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Patients%20can%20usually%20expect%20to,been%20no%20improvement%20in%20the
2025-09-04 13:07:40,297 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Patients%20can%20usually%20expect%20to,promptly%20by%20a%20physician%20to
2025-09-04 13:07:40,977 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1600 tokens streamed
2025-09-04 13:07:41,797 - src.streaming - INFO - ðŸ”— Citation found (annotation): Antibiotic susceptibility of urine culture specimens in Ontario: a population-based cohort study - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC9744262/#:~:text=Organism%20Escherichia%20coli%20%20,0
2025-09-04 13:07:43,521 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1650 tokens streamed
2025-09-04 13:07:46,353 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Uncomplicated%5E%7B,%E2%80%A2%E2%80%83Ceftriaxone%20IV%20%C2%B1%20ampicillin%20IV
2025-09-04 13:07:47,019 - src.streaming - INFO - ðŸ”— Citation found (annotation): Quality of antibiotic prescribing for outpatient cystitis in adult females | Journal of the Association of Medical Microbiology and Infectious Disease Canada - https://utppublishing.com/doi/10.3138/jammi-2023-0031#:~:text=prescriptions%20per%201%2C000%20population,therapy%2C%20followed%20by%205%2C%20then
2025-09-04 13:07:47,971 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1700 tokens streamed
2025-09-04 13:07:48,964 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Patients%20can%20usually%20expect%20to,been%20no%20improvement%20in%20the
2025-09-04 13:07:50,705 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=to%20the%20aforementioned%20factors%20should,emergency%20medical%20assessment%2C%20if%20present
2025-09-04 13:07:51,097 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1750 tokens streamed
2025-09-04 13:07:53,339 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1800 tokens streamed
2025-09-04 13:07:55,654 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1850 tokens streamed
2025-09-04 13:07:58,077 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=UTI%20is%20defined%20as%20a,10%2C10%20%2C%2018
2025-09-04 13:07:58,303 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1900 tokens streamed
2025-09-04 13:07:58,305 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=In%20women%20with%20dysuria%2C%20if,18
2025-09-04 13:08:00,543 - src.streaming - INFO - Candidate B[o4-mini-deep-research-2025-06-26] (full): 1950 tokens streamed
2025-09-04 13:08:01,926 - src.streaming - INFO - ðŸ”— Citation found (annotation): Recommendations on Bacterial Infections Treatment - UHN - https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=UTI%20with%20NO%20systemic%20involvement,3%20days%20Fosfomycin%3A%201%20day
2025-09-04 13:08:02,743 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Uncomplicated%5E%7B,%E2%80%A2%E2%80%83Ceftriaxone%20IV%20%C2%B1%20ampicillin%20IV
2025-09-04 13:08:03,430 - src.streaming - INFO - ðŸ”— Citation found (annotation): Antibiotic susceptibility of urine culture specimens in Ontario: a population-based cohort study - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC9744262/#:~:text=Organism%20Escherichia%20coli%20%20,0
2025-09-04 13:08:04,341 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=UTI%20is%20defined%20as%20a,10%2C10%20%2C%2018
2025-09-04 13:08:04,700 - src.streaming - INFO - ðŸ”— Citation found (annotation): The assessment and management of urinary tract infections in adults: Guidelines for pharmacists - PMC - https://pmc.ncbi.nlm.nih.gov/articles/PMC5582677/#:~:text=Patients%20can%20usually%20expect%20to,promptly%20by%20a%20physician%20to
2025-09-04 13:08:06,233 - src.streaming - INFO - Full answer streaming complete - approximately 1975 tokens
2025-09-04 13:08:06,241 - src.race - INFO - ================================================================================
2025-09-04 13:08:06,241 - src.race - INFO - Run complete!
2025-09-04 13:08:06,241 - src.race - INFO - ================================================================================
2025-09-04 13:08:06,246 - __main__ - INFO - {
  "previews": [
    "{\n  \"approach\": \"Produce a concise, provider-ready markdown plan for uncomplicated cystitis tailored to CA-ON, prioritizing first-line agents (nitrofurantoin/fosfomycin), stewardship, and safety checks (renal, pregnancy, G6PD, DDIs). Include clear monitoring and follow-up triggers.\",\n  \"evidence_plan\": \"1) IDSA/ESCMID acute uncomplicated cystitis guideline 2010 + updates/Practice Guidance 2024\u20132025 (site:idsociety.org, academic.oup.com). 2) Public Health Ontario provincial/community antibiograms 2023\u20132025 for E. coli urine (nitrofurantoin, TMP-SMX, ciprofloxacin, fosfomycin). 3) AMMI Canada/CADTH summaries on UTI therapy and fosfomycin use in Canada. 4) Choosing Wisely Canada on UTI testing/antibiotics. 5) Nitrofurantoin renal cutoff (CrCl <30 m",
    "{\"approach\":\"Determine that Sarah\u2019s presentation (dysuria/urgency without systemic signs or risk factors) fits acute uncomplicated cystitis. Use evidence-based guidelines to select first-line therapy (nitrofurantoin) and alternatives, tailored to patient specifics and local resistance. Organize the document by required sections, ensuring clear rationale and actionable instructions.\",\"evidence_plan\":\"Search IDSA/Canadian UTI guidelines (e.g., IDSA-2011 update) for first-line choices and dosing ([journals.lww.com](https://journals.lww.com/infectdis/Fulltext/2011/07000/Highlights_From_International_Clinical_Practice.15.aspx#:~:text=,ofloxacin%2C%20ciprofloxacin%2C%20and%20levofloxacin%20are)) ([www.uhn.ca](https://www.uhn.ca/corporate/AboutUHN/Quality_Patient_Safety/Antimicrobial-Stewardship/Pages/treatments.aspx#:~:text=Syndrome%20%20,3%20days%20Fosfomycin%3A%201%20day)). Search Ontario antibiotic susceptibility (e.g., CMAJOpen 2022) for local resistance data ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9744262/#:~:text=Organism%20Escherichia%20coli%20%20,14.0)). Search nitrofurantoin/TMP-SMX contraindications and dosing (e.g., drug database or UpToDate). Search UTI differential (e.g., StatPearls Dysuria) ([www.ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/sites/books/NBK549918/#:~:text=Etiology)) ([www.ncbi.nlm.nih.gov](https://www.ncbi.nlm.nih.gov/sites/books/NBK549918/#:~:text=Dysuria%20typically%20affects%20approximately%203,6)) and 72h follow-up recommendations.\",\"answer_outline\":\"- Executive Summary: Case snapshot (healthy 28F, symptoms) and plan (diagnosis + therapy).\\n- Deterministic",
    "```json\n{\n  \"approach\": \"Develop a thorough UTI assessment and management plan tailored to Sarah's demographics and clinical presentation, grounded in evidence-based guidelines.\",\n  \"evidence_plan\": \"Search for current UTI management guidelines in Ontario, CA, focusing on antibiotic resistance patterns, treatment protocols, and follow-up recommendations. Expected evidence includes regional treatment guidelines from health authorities, articles on UTI management, and recent studies.\",\n  \"answer_outline\": [\n    \"Executive Summary\",\n    \"Deterministic Assessment\",\n    \"Treatment Recommendation\",\n    \"Safety Validation\",\n    \"Clinical Reasoning Narrative\",\n    \"Prescribing Considerations for CA-ON\",\n    \"Research Summary with citations\",\n    \"72-Hour Follow-Up Plan\",\n    \"Diagnosis Brief\"\n  ],\n  \"assumptions\": \"Assumes no underlying complications or resistance issues; validate through regional guidelines and latest research.\",\n  \"risks\": \"Potential for overlooking antibiotic resistance; mitigate by researching local resistance patterns. Risk of misdiagnosis; ensure thorough differential diagnosis included.\",\n  \"confidence\": 0.",
    "{\n  \"approach\": \"Structure a guideline-driven assessment and plan tailored to a healthy young woman presenting with uncomplicated lower urinary tract symptoms. Integrate CA-ON resistance data and monitoring best practices.\",\n  \"evidence_plan\": \"1. Review CA-ON UTI empirical treatment guidelines. 2. Search regional E. coli resistance rates to nitrofurantoin, TMP-SMX, fosfomycin. 3. Confirm the latest safety guidance (renal, pregnancy, DDIs). 4. Screen for practice-changing guideline updates (IDSA, CA-ON ministries).\",\n  \"answer_outline\": [\n    \"Executive Summary: Key findings and safe management plan.\",\n    \"Deterministic Assessment: Algorithmic rationale\u2014meets uncomplicated cystitis criteria.\",\n    \"Treatment Recommendation: Agent, dose, duration; viable alternatives; clear contraindications.\",\n    \"Safety Validation: DDIs, renal/pregnancy status, rejection/approval logic, monitoring plan.\",\n    \"Clinical Reasoning Narrative: Differential dx (cystitis, vul",
    "```json\n{\n  \"approach\": \"Develop a UTI assessment and management plan for Sarah using evidence-based guidelines, considering symptoms, regional resistance in CA-ON, and patient history.\",\n  \"evidence_plan\": \"Search for guidelines on UTI treatment in non-pregnant females, CA-ON resistance data, and studies on UTI management. Evidence includes local antimicrobial susceptibilities and differential diagnosis criteria.\",\n  \"answer_outline\": [\n    \"Executive Summary: Overview of Sarah's UTI management plan.\",\n    \"Deterministic Assessment: Use an algorithm to determine uncomplicated UTI; rationale based on symptoms and history.\",\n    \"Treatment Recommendation: First-line antibiotic regimen, doses, alternatives, and contraindications.\",\n    \"Safety Validation: Drug-drug interactions, renal safety, monitoring needs.\",\n    \"Clinical Reasoning: Confidence in differential diagnosis.\",\n    \"Prescribing Considerations: Tailored to CA-ON resistance patterns.\",\n    \"Research Summary: Key references supporting recommendations.\",\n    \"72-Hour Follow-Up Plan: Symptoms to monitor, when"
  ],
  "tokens": [
    200,
    200,
    200,
    200,
    200
  ],
  "judge_scores": [
    {
      "index": 0,
      "relevance": 0.7,
      "coverage": 0.8,
      "faithfulness": 0.8,
      "overall": 0.75
    },
    {
      "index": 1,
      "relevance": 0.9,
      "coverage": 0.95,
      "faithfulness": 0.95,
      "overall": 0.9
    },
    {
      "index": 2,
      "relevance": 0.6,
      "coverage": 0.6,
      "faithfulness": 0.7,
      "overall": 0.65
    },
    {
      "index": 3,
      "relevance": 0.8,
      "coverage": 0.85,
      "faithfulness": 0.85,
      "overall": 0.8
    },
    {
      "index": 4,
      "relevance": 0.75,
      "coverage": 0.8,
      "faithfulness": 0.8,
      "overall": 0.77
    }
  ],
  "winner_index": 1,
  "winner_agent": "Candidate B[o4-mini-deep-research-2025-06-26] (full)",
  "agent_models": [
    "gpt-5",
    "o4-mini-deep-research-2025-06-26",
    "gpt-4o-mini",
    "gpt-4.1",
    "gpt-4o"
  ],
  "judge_model": "gpt-4o",
  "strategy": "bandit"
}